{"name":"23andMe, Inc.","slug":"23andme-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":219638000,"revenueGrowth":-26.7,"grossMargin":45.5,"rdSpend":101590000,"netIncome":-280885000,"cash":38248000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"23ME-00610","genericName":"23ME-00610","slug":"23me-00610","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"23ME-00610","genericName":"23ME-00610","slug":"23me-00610","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa0RiR1QwdU1iWFp5VHprOUh5R3R5MGtvQktUSnRxemJtb0tNMFBsa1JSU3gyQVdBWUhQWG5RSWNvSEhTOVdYT3FBN0pkaktBNEFQZURZVEQ1U3VYeldEbWdzcFFHbnphVW9WQXFoX1V6YXB0em1jUVA2TURFWXlrOS1xbjQtZnRwc2hfY25fYk5BWVJZ0gGaAUFVX3lxTFA4Q18zYUVkT2ZqWlJ1dHVKVnNMRWhpTi0xcnM0UEJ3MUNvV2htTUVoR3VrMnY3RWdJeHhTY2ZvT0M4NTlIR1dSQXdJbG1UbEZpLVl6UGM2aHBsWExjZXptSEpubHg0NDBZTzNOUU9vQ0Z6U0NJQkRSMUl1WF9qeUtRRUJxQmk2WmE3dDFfVDktelpZREk4TkJkSWc?oc=5","date":"2026-02-15","type":"deal","source":"ABC News","summary":"Regeneron Pharmaceuticals to buy 23andMe for $256M - ABC News","headline":"Regeneron Pharmaceuticals to buy 23andMe for $256M","sentiment":"neutral"},{"date":"2025-12-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-10-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-10-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-09-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-09-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-08-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-08-04","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOdXdZWVp1SEVvdV9IeGtmdWpRSHhWQ2otRDA4eHVwYjhEZ2h5QnRlNW9aMjFGZWVPNTdJT2psUjhtc0VuN2liUlU5T09YLU9SUnVfc1E1LWZ6T2pDR2pUWk03YTlEazhUbTQ5RUlmYnpFYWZYR0lKRW11Q3U1eEx6SmhCSnJBQl9wNHdTUkJLNkZvdTQ?oc=5","date":"2025-07-25","type":"deal","source":"Yahoo Finance","summary":"Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal - Yahoo Finance","headline":"Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal","sentiment":"neutral"},{"date":"2025-07-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-06-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":219638000,"revenuePeriod":"2024-03-31","revenueHistory":[{"value":219638000,"period":"2024-03-31"},{"value":299489000,"period":"2023-03-31"},{"value":271893000,"period":"2022-03-31"},{"value":243920000,"period":"2021-03-31"},{"value":305463000,"period":"2020-03-31"}],"grossProfit":100004000,"grossProfitHistory":[],"rdSpend":101590000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-280885000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":38248000,"cashHistory":[],"totalAssets":159894000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}